Your browser doesn't support javascript.
loading
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.
Tsui, Dana Wai Yi; Murtaza, Muhammed; Wong, Alvin Seng Cheong; Rueda, Oscar M; Smith, Christopher G; Chandrananda, Dineika; Soo, Ross A; Lim, Hong Liang; Goh, Boon Cher; Caldas, Carlos; Forshew, Tim; Gale, Davina; Liu, Wei; Morris, James; Marass, Francesco; Eisen, Tim; Chin, Tan Min; Rosenfeld, Nitzan.
Afiliación
  • Tsui DWY; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Murtaza M; Cancer Research UK Major Center - Cambridge, Cambridge, UK.
  • Wong ASC; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Rueda OM; Cancer Research UK Major Center - Cambridge, Cambridge, UK.
  • Smith CG; Department of Oncology, University of Cambridge, Cambridge, UK.
  • Chandrananda D; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Soo RA; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Lim HL; Cancer Research UK Major Center - Cambridge, Cambridge, UK.
  • Goh BC; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Caldas C; Cancer Research UK Major Center - Cambridge, Cambridge, UK.
  • Forshew T; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Gale D; Cancer Research UK Major Center - Cambridge, Cambridge, UK.
  • Liu W; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Morris J; Cancer Science Institute, Centre for Translational Medicine, National University of Singapore, Singapore, Singapore.
  • Marass F; Parkway Cancer Center, Singapore, Singapore.
  • Eisen T; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Chin TM; Cancer Science Institute, Centre for Translational Medicine, National University of Singapore, Singapore, Singapore.
  • Rosenfeld N; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
EMBO Mol Med ; 10(6)2018 06.
Article en En | MEDLINE | ID: mdl-29848757
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Gefitinib / Hidroxicloroquina / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Gefitinib / Hidroxicloroquina / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido